Ekso Bionics Holdings Inc (NAS:EKSO)
$ 0.61 0.005 (0.83%) Market Cap: 13.31 Mil Enterprise Value: 11.08 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 60/100

Q3 2020 Ekso Bionics Holdings Inc Earnings Call Transcript

Oct 29, 2020 / 08:30PM GMT
Release Date Price: $4.18 (+0.97%)
Operator

Greetings and welcome to the Ekso Bionics Third Quarter 2020 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

For opening remarks, I'd now like to turn the call over to David Carey of Lazar Partners. Thank you, David. You may begin.

David Carey
Lazar Partners Ltd. - MD of IR

Thank you, operator, and thank you all for participating in today's call. Joining me from Ekso Bionics are Jack Peurach, President and Chief Executive Officer; Jack Glenn, Chief Financial Officer; and Bill Shaw, Chief Commercial Officer.

Earlier today, Ekso Bionics released financial results for the quarter ended September 30, 2020. A copy of the press release is available on the company's website.

Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot